Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Zylox-Tonbridge and GL Capital Announce Strategic Investment in LifeTech Scientific to Build a Leading Vascular and Structural Heart Intervention Platform
06 Nov 2026
PR Newswire Association LLC.
Smartee Shares Clinical Approaches to Growing Patients and Impacted Canines at EOSC 2026
06 Nov 2026
PR Newswire Association LLC.
Bio-Thera Announces NMPA Approval of BAT2506, the First Golimumab Biosimilar Approved in China
06 Nov 2026
PR Newswire Association LLC.
Antengene Announces First Patient Dosed in Phase I ATTRACT Study Evaluating ATG-201 (CD19 × CD3 TCE) for B Cell-Mediated Autoimmune Diseases
06 Nov 2026
PR Newswire Association LLC.
Abbott and Novo expand partnership to launch Plosbrio® broadening access to semaglutide for advanced diabetes care across Asia Pacific
05 Nov 2026
PR Newswire Association LLC.
Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer
05 Nov 2026
PR Newswire Association LLC.
WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence
04 Nov 2026
PR Newswire Association LLC.
CStone and Kimia Therapeutics Enter Clinical Development Collaboration to Advance a Novel Drug Candidate Targeting Repair Pathways Critical for Solid Tumor Survival
04 Nov 2026
PR Newswire Association LLC.
Lynk Pharmaceuticals Announces Commercialization Collaboration with Simcere for Zemprocitinib in Dermatology Indications, Further Expanding Product Commercialization Footprint
02 Nov 2026
PR Newswire Association LLC.
Asymchem Completes its First USFDA Pre-Approval Inspection (PAI) of the Tianjin 4 TIDES Manufacturing Site
29 Oct 2026
PR Newswire Association LLC.
Altruist Biologics' Integrated CMC Platform Supports NMPA Acceptance of NDA for Localized Manufacturing of Multinational Client's Biologic
29 Oct 2026
PR Newswire Association LLC.
Median PFS Approaches 14 Months! 3SBio's PD-1/VEGF Bispecific Antibody Posts Impressive Data at ESMO 2026
28 Oct 2026
PR Newswire Association LLC.
Asia-Pacific's First Whole-Body Clinical 5T MRI System Installed in Vietnam, Advancing a New Regional High-Field MRI Center of Excellence
27 Oct 2026
PR Newswire Association LLC.
IX at IPVS 2026: Listening to Global Voices, Partnering to Advance HPV Prevention
27 Oct 2026
PR Newswire Association LLC.
CityUHK researchers reveal how fructose can suppress liver cancer, opening a new therapeutic avenue
26 Oct 2026
GlobeNewswire
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
GlobeNewswire
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05 Aug 2026
GlobeNewswire
InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China
04 Aug 2026
GlobeNewswire
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
04 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases
04 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
GlobeNewswire
Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia
03 Aug 2026
GlobeNewswire
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
03 Aug 2026
Upcoming Events All Events
- November 2026
- Cologne: BIO-Europe® 2026
- London: LSX Investival Showcase London
- Zurich: AutomaPlus 2026